# Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow

> **NCT03551951** · — · RECRUITING · sponsor: **University of Missouri-Columbia** · enrollment: 320 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer
- Esophageal Cancer
- Gastric Cancer
- Pancreatic Cancer
- Hepatocellular Cancer
- Colorectal Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Test for circulating tumor cells, DNA alterations

## Key facts

- **NCT ID:** NCT03551951
- **Lead sponsor:** University of Missouri-Columbia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2016-07-01
- **Primary completion:** 2027-12-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 320 (ESTIMATED)
- **Last updated:** 2025-10-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03551951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03551951, "Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03551951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*